Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications
Links shared publicly online about this topic.
- 934total visits
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications
View full resource at medicalnewstoday.com
Tags: Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on August 20, 2010 at 3:00 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications http://mnt.to/3HDZ #neurology
Also Shared By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications - QualityPoint Technologies
qualitypointtech.net — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for Cymbalta (duloxetine HCl). The Committee's decision is not final - the FDA has to decide - however, the FDA usually goes along with what the Committee recommends. The Advisory Committee recommended the expanded use of Cymbalta for the treatment of chronic knee and lower back pain...” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 1:18 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications: The Anesthetic and Lif... http://bit.ly/cEcF29
Advertisement
MNT Health News
@mnt_healthnews
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications http://mnt.to/3HDZ #healthnews
1 year ago...